Industry
Biotechnology
Companies applying molecular biology to develop therapeutics and diagnostics. High-risk/high-reward: valuations tie to clinical trial success, intellectual property and partnerships with big pharma.
Total Companies
1 369
1 297 stocks
| Company | Last Price | Price Change | Market Cap | ||
|---|---|---|---|---|---|
|
|
|
Abbvie Inc
ABBV
|
$210.39 |
-0.2%
|
$372.1B |
|
|
|
Amgen Inc
AMGN
|
$326.31 |
-2.2%
|
$176.1B |
|
|
|
Gilead Sciences Inc
GILD
|
$129.58 |
-1.9%
|
$160.8B |
|
|
|
OpGen Inc
OPGN
|
$0.327 |
0%
|
$156.9B |
|
|
|
Vertex Pharmaceuticals Inc
VRTX
|
$436.95 |
-3%
|
$111.1B |
|
|
|
Regeneron Pharmaceuticals Inc
REGN
|
$698.25 |
-2.1%
|
$73.8B |
|
|
|
argenx SE
ARGX
|
€693.2 |
-0.1%
|
$50.3B |
|
|
|
Alnylam Pharmaceuticals Inc
ALNY
|
$286.98 |
-2.2%
|
$38.3B |
|
|
|
CSL Ltd
CSL
|
AU$97.96 |
+0.7%
|
$34.3B |
1 292 results hidden
Create a free account to unlock additional access and upgrade to see all results
Create Free Account
